Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusFeatures Index
Features for November 2002
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Creating a patient-centred NHS
Saturday , November 30, 2002
Now that the storm of Whitehall-led NHS reform appears to be abating, the long journey towards the ultimate aim of all the re-organisation has begun. ...(more)
Parallel trade: is pharma fighting a losing battle?
Saturday , November 30, 2002
IMS data suggest that by the end of 2002, 20% of all UK prescriptions dispensed will be parallel imports. Pharmafocus investigates one of pharma's most emotive issues....(more)
Cancer generics - a booming market
Saturday , November 30, 2002
Increasing blockbuster patent expiries combined with geographic market expansion will fuel healthy growth in the cancer generics market....(more)
  Launch summery...
Friday , November 29, 2002
Summer is never traditionally the best time to attract the attention of GPs with new drugs, so how have products launched in the middle of this year fared?...(more)
  Collaboration across the pharma industry
Monday , November 04, 2002
Coping with the "knowledge glut" is just one of the many reasons why collaboration is becoming ever more important for the pharma industry...(more)
  EDC: electronic data capture or eliminating data corruption?
Monday , November 04, 2002
Even in the best of circumstances, a drug spends 10 to 12 years of its 20-year patent life being tested and proven. So is the clinical trial a critical bottleneck, and what can be done to fix it?...(more)
  Is pharma forever in the box?
Monday , November 04, 2002
Can pharma ever embrace new marketing ideas?...(more)
  Does healthcare copywriting break the rules?
Monday , November 04, 2002
How far can healthcare copywriters keep within established rules and still ensure that they are really saying something to their target audience?...(more)
  Viagra in shape despite close shave
Monday , November 04, 2002
What do recent rulings mean for pharmaceutical companies that want to increase the trademark protection on their products? ...(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.